St. Joseph Krankenhaus Berlin-Tempelhof GmbH
- Address
- Budapester Strasse 15-19, Tiergarten, 10787 Berlin, Germany
St. Joseph Krankenhaus Berlin-Tempelhof GmbH - Colorectal Cancer Research Center
St. Joseph Krankenhaus Berlin-Tempelhof GmbH is a leading clinical research institution specializing in innovative treatments for colorectal cancer. The center conducts advanced phase I/II trials investigating novel therapeutic combinations and precision medicine approaches for patients with both early-stage and metastatic colorectal carcinoma.
- Advanced and chemorefractory colorectal cancer treatment strategies combining D,L-methadone with mFOLFOX6 chemotherapy
- Adjuvant therapy optimization for UICC stage II colon and rectal cancer using ctDNA biomarker-guided approaches
- Disease control rate evaluation and long-term survival outcomes in metastatic colorectal cancer patients
The research program emphasizes personalized oncology through biomarker analysis, including circulating tumor DNA (ctDNA) monitoring to guide treatment decisions. Their clinical trials focus on maximizing therapeutic efficacy while carefully evaluating toxicity profiles and determining optimal dosing strategies for novel drug combinations in the treatment of advanced gastrointestinal malignancies.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in St. Joseph Krankenhaus Berlin-Tempelhof GmbH
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of BAY 3018250 in Symptomatic Proximal Deep Vein Thrombosis: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial | Bayer AG | Phase II | Not Recruiting | Dec 2023 | Dec 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bay 3018250 | 1 | Unknown | 2023-12-20 | 2023-12-20 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.